beta-lactams has been researched along with HbS Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gallien, S; Habibi, A; Hulin, A; Huriez, P; Lepeule, R; Ourghanlian, C; Razazi, K; Vindrios, W | 1 |
| Guo, X; He, Y; Wang, ZJ | 1 |
| Cecchini, J; Habibi, A; Hulin, A; Mekontso Dessap, A; Razazi, K | 1 |
3 other study(ies) available for beta-lactams and HbS Disease
| Article | Year |
|---|---|
Probenecid, an old β-lactams pharmacokinetic enhancer for a renewed use: A retrospective study.
Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; beta-Lactams; Humans; Probenecid; Retrospective Studies | 2022 |
Therapeutic potential of β-lactam ceftriaxone for chronic pain in sickle cell disease.
Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Chronic Pain; Humans | 2023 |
Profound underdosing of β-lactams in patients with sickle-cell disease.
Topics: Amoxicillin; Anemia, Sickle Cell; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefotaxime; Humans; Prospective Studies | 2018 |